Financial Times

New data on Lilly's investigational treatment olomorasib at ESMO 2026 show durable first-line activity in KRAS G12C-mutant non-small cell lung cancer – Company Announcement - FT.com - Financial Times

2026-10-25

Johnson & Johnson reports 75% tumor response rate in advanced prostate cancer with JNJ-6143, a first-in-class RIPTAC™ molecule – Company Announcement - FT.com - Financial Times

2026-10-25

BioNTech and Bristol Myers Squibb Report Encouraging Global Phase 2 Data for Pumitamig in Advanced NSCLC After Progression on Immunotherapy Plus Chemotherapy – Company Announcement - FT.com - Financia

2026-10-25

Ping An Highlights Green Development Initiatives at International Communication Seminar in Shenzhen Ahead of APEC 2026 – Company Announcement - FT.com - Financial Times

2026-10-25

2026 ESMO | Innovent Presented Phase 1 Study Data for IBI3001, a First-in-Class EGFR/B7H3 Bispecific ADC - Financial Times

2026-10-25

2026 ESMO | Innovent Announcement Phase 2 Data Presentation for IBI354 (HER2 ADC) In First-line Treatment of Breast Cancer – Company Announcement - Financial Times

2026-10-25

Eight delicious pumpkin recipes - Financial Times

2026-10-25

‘Designer baby’ start-ups test limits of biotech taboo - Financial Times

2026-10-25

Conservatives and Reform ready their attacks on John Healey’s Budget - Financial Times

2026-10-25

Many care homes in England have never been inspected by regulator - Financial Times

2026-10-25

What my most embarrassing job interview taught me - Financial Times

2026-10-25

Martin Wolf on the US midterms: What’s at stake for the world? - Financial Times

2026-10-25

Mercuria challenging the ‘Dow Jones of shipping’ in court after Hormuz losses - Financial Times

2026-10-25

Luxury groups’ value drops by €250bn as Chinese consumer demand fades - Financial Times

2026-10-25

Bolsonaro and Lula face off in knife-edge Brazil election - Financial Times

2026-10-25

Why is it getting harder to raise taxes in the UK? - Financial Times

2026-10-25

Life after USAID in Somalia - Financial Times

2026-10-25

The Black Sea is now the world’s deadliest shipping route - Financial Times

2026-10-25

The right’s obsession with ‘civil war’ in Britain - Financial Times

2026-10-25

More than 1mn antiquities returned to countries of origin - Financial Times

2026-10-25

Climate accounting body in battle over corporate ‘capture’, say staff - Financial Times

2026-10-25

Billionaire benevolence is booming, but it comes with strings - Financial Times

2026-10-25

The Bethlehem Project: Voters feel anxious and uncertain as US midterms near - Financial Times

2026-10-25

Steven Bernard - Financial Times

2026-10-25

SoftBank-backed drone maker wants every farmer to ‘have their own robot’ - Financial Times

2026-10-25

Why 17 is not the magic number in industrial policy - Financial Times

2026-10-25

Australia’s treasurer says middle powers should co-operate to avoid being hostage to geopolitics - Financial Times

2026-10-25

What's On | Energy Transition Summit - Financial Times

2026-10-24

Sunday Number 168: News Puzzle - Financial Times

2026-10-24

Skema Business School - Business school rankings from the Financial Times - FT.com - Financial Times

2026-10-24

Climb Bio Presents Initial PrisMN Phase 2 Data from Budoprutug in pMN at an Oral Session at ASN Kidney Week 2026 - Financial Times

2026-10-24

Europe Express - Financial Times

2026-10-24

Israel central bank rejects Netanyahu’s plan to use crypto to evade sanctions - Financial Times

2026-10-24

Axon Announces Body 5: Next-Generation Camera Built for the AI Era - Financial Times

2026-10-24

Kim reaffirms ties with China amid worries over Russian friendship - Financial Times

2026-10-24

Pfizer's 25-Valent Pediatric Pneumococcal Conjugate Vaccine Candidate Shows Robust Phase 2 Data at IDWeek 2026 - Financial Times

2026-10-24

IMFINZI® (durvalumab) plus tarlatamab-dlle reduced the risk of death by 58% in 1st-line extensive-stage small cell lung cancer in the DeLLphi-305 Phase III trial – Company Announcement - FT.com - Fina

2026-10-24

IMDELLTRA® IN COMBINATION WITH IMFINZI® REDUCED RISK OF DEATH BY AN UNPRECEDENTED 58% IN FIRST-LINE EXTENSIVE STAGE SMALL CELL LUNG CANCER – Company Announcement - FT.com - Financial Times

2026-10-24

Perioperative IMFINZI® (durvalumab) plus neoadjuvant enfortumab vedotin reduced risk of recurrence by 49% and risk of death by 42% in muscle-invasive bladder cancer – Company Announcement - FT.com - F

2026-10-24

Mayfair club Maison Estelle set to reopen after alleged firearm incident - Financial Times

2026-10-24

Johnson & Johnson announces ERLEADA® (apalutamide) treatment before and after surgery reduces risk of recurrence or death by 62% versus surgery alone in high-risk prostate cancer – Company Announcemen

2026-10-24

ESMO 2026: NUBEQA® (darolutamide) Plus ADT and Radiation Therapy Reduces Risk of Metastasis or Death by 58% in Prostate Cancer Patients at High Risk of Recurrence – Company Announcement - FT.com - Fin

2026-10-24

Semtech Brings 5G Network Slicing, FIPS 140-3 to IACP 2026 – Company Announcement - Financial Times

2026-10-24

Davos in the Desert’s ‘old fox’ Richard Attias faces his latest test - Financial Times

2026-10-24

Incyte and Genmab Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer - Financial Times

2026-10-24

Ukraine military says Starlink service restrictions have been removed - Financial Times

2026-10-24

Tom Matsuda - Financial Times

2026-10-24

Chart of the Week: French government and corporate bond yields are converging - Financial Times

2026-10-24

NANOBIOTIX Announces Final Data from Phase 1 Study Evaluating JNJ-1900 (NBTXR3) With Immune Checkpoint Inhibitors as a 2L+ Therapy in Anti-PD-1-Resistant Primary Cutaneous Melanoma – Company Announcem

2026-10-24

Genmab and Incyte Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer - Financial Times

2026-10-24